The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activity.Peter J. Tummino, Donald Hupe, Jackson D. Scholten et al.|Proceedings of the National Academy of Sciences|1996Cited by 81
The human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activitiesPeter J. Tummino, Donald Hupe, Thomas J. McQuade et al.|Antimicrobial Agents and Chemotherapy|1997Cited by 45
A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: The 2,2′-dithiobisbenzamidesJohn M. Domagala, Robert Schultz, John P. Bader et al.|Bioorganic & Medicinal Chemistry|1997Cited by 42
2,2'-Dithiobisbenzamides and 2-benzisothiazolones, two new classes of antiretroviral agents: SAR and mechanistic considerations.Domagala Jm, Thomas J. McQuade, Rocco D. Gogliotti et al.|PubMed|1997Cited by 8